1[1]Laso FJ, lglesias Osma C, Ciudad J, et al. Chronic alcoholism is associated with an imbalanced production of Th-l/Th-2 cytokines by peripheral blood T cells. Alcohol Clin Exp Res, 1999,23 (8): 1306-11 被引量：1
2[2]Sakaida I, Nagatomi A, Hironaka K, et al. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy. Am J Gastroenterol, 1999,94(2) :489-96 被引量：1
3[3]Willson RA, Fischer SH, Ochs HD. Long-term interferon alpha maintenance therapy for chronic hepatitis C infection in a patient with common variable immune deficiency. J Clin Gastroenterol, 1999,29 (2): 203-6 被引量：1
4[4]Ishibashi K, Kashiwagi T, Ito A, et al. Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C. Hepatology, 1996,24 (1):27-31 被引量：1
5[5]Beichard O, Glaumann H, Fry den A, et al. Long-term follow-up of chronic hepatitis C patients with sustained virological response to α-interferon. J Hepatol, 1999,30(5) :783-7 被引量：1
6[6]Numaguchi S, Okuno M, Moriwaki H, et al. Modulation of collagen synthesis and degradation by retinoids and cytokines in 3T3 L1 preadipocytes. Intern Med, 1994,33(6) :309-16 被引量：1
7[7]Moreno MG, Muriel P. Remission of liver fibrosis by interferon-alpha 2b. Biochem Pharmacol, 1995,50(4) :515-20 被引量：1
8[8]Fabris P,Marranconi F,Bozzola L,et al. Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFN. J Gastroenterol, 1999,34(3) :345-50 被引量：1
9[9]Ajello A, Freni MA, Spadaro A, et al. Ten year follow-up of patients with chronic hepatitis C treated with interferon. Hepatogastroenterology, 1999,46 (28) :2447-50 被引量：1
10[10]Dufour JF, DeLellis R, Kaplan MM. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Dig Dis Sci, 1998,43(12) :2573-6 被引量：1
7Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
